BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND NUP214, ENSG00000126883, 8021, MGC104525, D9S46E, RP11-544A12_7, N214, CAIN, P35658, CAN AND Staging
721 results:

  • 1. [Analysis of sequential chemotherapy efficacy in ovarian epithelial carcinoma, fallopian tube carcinoma and primary peritoneal carcinoma].
    Shen XY; Li XP; Wang Y; Wu Y; Li Y; Yang YC; Wei LH; Fan Y; Tang ZQ
    Zhonghua Fu Chan Ke Za Zhi; 2024 May; 59(5):383-390. PubMed ID: 38797568
    [No Abstract]    [Full Text] [Related]  

  • 2. Diagnosing and staging epithelial ovarian cancer by serum glycoproteomic profiling.
    Dhar C; Ramachandran P; Xu G; Pickering C; Čaval T; Wong M; Rice R; Zhou B; Srinivasan A; Aiyetan P; Chu CW; Moser K; Herzog TJ; Olawaiye AB; Jacob F; Serie D; Lindpaintner K; Schwarz F
    Br J Cancer; 2024 Jun; 130(10):1716-1724. PubMed ID: 38658783
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Primary lymphoma of the female genital tract masquerading as gynecological malignancy.
    Shi S; Li W; Ni G; Ding J; Liu Y; Wu H; Zhang Z; Ding Z
    BMC Womens Health; 2024 Apr; 24(1):247. PubMed ID: 38637800
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Molecular and pathologic data to guide selection of patients with endometrioid endometrial cancer for ovarian preservation.
    Manning-Geist BL; Rios-Doria E; Liu YL; Ellenson LH; Zhou QC; Iasonos A; Leitao MM; Abu-Rustum NR; Weigelt B; Mueller JJ
    Int J Gynecol Cancer; 2024 May; 34(5):697-704. PubMed ID: 38508587
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Identification of prognostic factors and construction of nomogram to predict cancer-specific survival for patients with ovarian granulosa cell tumors.
    Zhang Y; Zhang Z; Ding X; Zhang K; Dai Y; Cheng W; Luo C
    Cancer Rep (Hoboken); 2024 Mar; 7(3):e2046. PubMed ID: 38507268
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Sentinel Node Mapping in ovarian Tumors: A Study Using Lymphoscintigraphy and SPECT/CT.
    Ataei Nakhaei S; Sadeghi R; Mostafavi SM; Treglia G; Hassanzadeh M; Esmaeilpour M; Taheri NS; Farazestanian M
    Contrast Media Mol Imaging; 2024; 2024():5453692. PubMed ID: 38435483
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Laparoscopic versus laparotomic surgical treatment in apparent stage I ovarian cancer: a multi-center retrospective cohort study.
    Zhang J; Li M; Feng L; Zhai Y; Wang L; Chen Y
    World J Surg Oncol; 2024 Feb; 22(1):62. PubMed ID: 38389046
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Differentiation of survival outcomes by anatomic involvement and histology with the revised 2023 International Federation of Gynecology and Obstetrics staging system for endometrial cancer.
    Gravbrot N; Weil CR; DeCesaris CM; Gaffney DK; Suneja G; Burt LM
    Eur J Cancer; 2024 Apr; 201():113913. PubMed ID: 38377777
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Assessment of endometrial carcinoma on biopsy as a predictor of final surgical pathology: Are we doing it right? A completed audit cycle and recommendations.
    Jassar A; Hemali N; Bhatnagar A
    Indian J Pathol Microbiol; 2024; 67(1):68-73. PubMed ID: 38358191
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Clinicopathological pattern of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 over-expression of epithelial ovarian carcinomas in Nigeria.
    Ajani MA; Lawan A; Oke T; Khramtsova G; Nwanji I; Salami A; Awolude O; Ebili H; Onwukamuche ME; Sveen E; Yoshimatsu T; Olopade OI
    Afr Health Sci; 2023 Sep; 23(3):236-244. PubMed ID: 38357171
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Is minimally invasive surgical approach a reasonable option in apparent early stage epithelial ovarian cancer restaging? Results from a multicentric retrospective study.
    Mokarram Dorri N; Del M; Cannone F; Lefebvre M; Loaec C; Sabiani L; Jauffret C; Blache G; Houvenaeghel G; Carcopino X; Classe JM; Narducci F; Martinez A; Lambaudie E
    Eur J Surg Oncol; 2024 Mar; 50(3):107976. PubMed ID: 38354484
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Is routine gastrointestinal endoscopy required in every woman with mucinous ovarian cancer? An analysis of survival rates and metastatic tumours in a cancer centre.
    Katsanevakis E; Addo-Yobo W; Bharathan B; Loona A; Gan C; Nunns D; Gajjar K
    Eur J Obstet Gynecol Reprod Biol; 2024 Mar; 294():105-110. PubMed ID: 38237307
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Trends in the incidence and survival outcomes of endometrial cancer in Korea: a nationwide population-based cohort study.
    Shim SH; Lim J; Kim JH; Lee YJ; Ha HI; Lim MC; Won YJ
    J Gynecol Oncol; 2024 May; 35(3):e32. PubMed ID: 38130136
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Effects of epidural anesthesia on the prognosis of ovarian cancer-a systematic review and meta-analysis.
    Shen H; Pang Q; Gao Y; Liu H
    BMC Anesthesiol; 2023 Nov; 23(1):390. PubMed ID: 38030996
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Sentinel-node biopsy in apparent early stage ovarian cancer: final results of a prospective multicentre study (SELLY).
    Nero C; Bizzarri N; Di Berardino S; Sillano F; Vizzielli G; Cosentino F; Vargiu V; De Iaco P; Perrone AM; Vizza E; Chiofalo B; Uccella S; Ghezzi F; Turco LC; Corrado G; Giannarelli D; Pasciuto T; Zannoni GF; Fagotti A; Scambia G
    Eur J Cancer; 2024 Jan; 196():113435. PubMed ID: 38006759
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Early-stage serous fallopian tube carcinoma.
    Khromchenko K; Aikman N; Sun X; ElSahwi K
    BMJ Case Rep; 2023 Nov; 16(11):. PubMed ID: 37996138
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Oncologic outcomes of robot-assisted laparoscopy versus conventional laparoscopy for the treatment of apparent early-stage endometrioid adenocarcinoma of the uterus.
    Lim YH; Dagher C; Abu-Rustum NR; Mueller JJ; Sonoda Y; Zivanovic O; Broach V; Leitao MM
    Gynecol Oncol; 2023 Dec; 179():152-157. PubMed ID: 37980770
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Out-of-pocket cost by cancer stage at diagnosis in commercially insured patients in the United States.
    McGarvey N; Gitlin M; Fadli E; Chung KC
    J Med Econ; 2023; 26(1):1318-1329. PubMed ID: 37907436
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Lymph node staging in grade 1-2 endometrioid ovarian carcinoma apparently confined to the ovary: Is it worth?
    Bizzarri N; Imterat M; Fruscio R; Giannarelli D; Perrone AM; Mancari R; Traut A; Rosati A; du Bois A; Ferrari D; De Iaco P; Ergasti R; Ataseven B; Bianchi T; Di Stanislao M; Perri MT; Heitz F; Concin N; Fanfani F; Vizza E; Scambia G; Harter P; Fagotti A
    Eur J Cancer; 2023 Dec; 195():113398. PubMed ID: 37890354
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Nomogram incorporating log odds of positive lymph nodes improves prognostic prediction for ovarian serous carcinoma: a real-world retrospective cohort study.
    Zhang S; Liu X; Li Q; Pan Y; Tian Y; Gu X
    BMJ Open; 2023 Oct; 13(10):e074206. PubMed ID: 37865413
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 37.